National Research (NASDAQ:NRC) Sees Large Volume Increase

National Research Co. (NASDAQ:NRCGet Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 178,489 shares changed hands during trading, an increase of 124% from the previous session’s volume of 79,638 shares.The stock last traded at $22.94 and had previously closed at $23.00.

National Research Price Performance

The company has a 50 day moving average of $29.28 and a 200 day moving average of $35.60. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $548.05 million, a price-to-earnings ratio of 18.51 and a beta of 0.56.

National Research (NASDAQ:NRCGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 EPS for the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%. The business had revenue of $35.31 million during the quarter.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.48 annualized dividend and a yield of 2.09%. National Research’s dividend payout ratio is currently 38.71%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NRC. Vanguard Group Inc. grew its stake in National Research by 1.1% in the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after purchasing an additional 10,454 shares in the last quarter. Conestoga Capital Advisors LLC increased its stake in National Research by 0.5% during the first quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company’s stock valued at $31,080,000 after purchasing an additional 3,850 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of National Research by 1.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after buying an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. acquired a new stake in National Research during the third quarter worth about $11,124,000. Finally, Comerica Bank acquired a new position in National Research in the third quarter valued at approximately $6,939,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

See Also

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.